The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract
Modlin I, Kidd M, Bodei L, Drozdov I, Aslanian H. The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract. The American Journal Of Gastroenterology 2015, 110: 1223. PMID: 26032155, DOI: 10.1038/ajg.2015.160.Peer-Reviewed Original ResearchConceptsPancreatic neuroendocrine tumorsNeuroendocrine tumorsCgA measurementMalignant gastrointestinal diseasesBlood-based biomarkersNeuroendocrine tumor diseaseExtensive diseaseIntestinal carcinoidsColorectal cancerGastrointestinal diseasesCgA levelsPancreatic diseaseClinical utilityGastrointestinal tractDiagnostic strategiesNETestDiseaseTumorsNETest scoreTumor diseaseNovel bloodNational InstituteDiagnosisBiomarkersCgA